Professional Documents
Culture Documents
Apart from that, we also have had kids presenting actively using these pills.
They haven’t overdosed yet but they’re asking for help to stop using these
pills.
Some things that we have noticed, and this is the trend across the DMV region
… the kids who are presenting to treatment, these are kids who are motivated
to stop – they predominantly identify as Hispanic in ethnicity. Most of them
have Medicaid for insurance.
A lot of them, you know, they come to us – the average age is about 16, 16½
and their first use of opioids, these pills, was about a year ago. So the average
first use was about 15 to 15½ years of age. They are really struggling, and they
want to get better.
There are various different reasons, one of which is just access. A lot of other
kids are using it. They’re using it in schools. They try it, they like it, and then
it escalates and they stop using other substances.
Most of these kids start off with crushing and try it nasally by snorting it and
then they transition to smoking. What they do is they put these pills on a piece
of aluminum foil, heat it up and inhale the fumes that come up. We haven’t
had anyone come in who reported using any of these pills intravenously.
Oftentimes, this is the first point of entry into opioid use for these kids.
Fentanyl, which is one of the most powerful opioids of abuse out there, is the
first point of entry into opioid use for these children.
Where for adults, they might have been prescribed pain medications. Or they
might have started on opioids through other routes and might have used less
potent products before transitioning to fentanyl.
With adolescents, now we are seeing that they can tell that they need help, and
they are motivated and they are entering treatment.
We have to take into account the presence of parents or guardians, how the
school system interacts with them, what else do they do in their communities.
There’s an increased association of violence and legal trouble that some of
these patients end up in that we need to address while treating them. And these
are some differences when it comes to treating adolescents versus adults.
The challenge is we can limit access and prevent these kids from getting the
pills. But then you have a huge population of kids who are dependent on these
pills, who can’t tolerate withdrawal symptoms, who have what we call opioid
use disorder. That is going to perpetuate the problem if we’re not treating
them. We need to do more in terms of increasing access to care for these kids.